🔗 Visit the ClinicalTrials.gov page for NCT01743014
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | IL-1β, RAGE and FABP4: targeting the dynamic trio in metabolic inflammation and related pathologies. | Future Med Chem | 2013 | 0.81 |
| 2 | Antiplatelet agents for chronic kidney disease. | Cochrane Database Syst Rev | 2022 | 0.75 |